- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 5/10 - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells
Patent holdings for IPC class C12N 5/10
Total number of patents in this class: 15117
10-year publication summary
|
692
|
786
|
786
|
915
|
914
|
1060
|
1106
|
1014
|
1084
|
320
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Pioneer Hi-Bred International, Inc. | 6264 |
708 |
| Kyoto University | 2732 |
304 |
| Monsanto Technology LLC | 7905 |
252 |
| Osaka University | 3143 |
157 |
| The Regents of the University of California | 18943 |
154 |
| Riken | 1669 |
141 |
| Regeneron Pharmaceuticals, Inc. | 3650 |
114 |
| Chugai Seiyaku Kabushiki Kaisha | 1259 |
111 |
| Daiichi Sankyo Company, Limited | 1829 |
108 |
| National Institute of Advanced Industrial Science and Technology | 3677 |
99 |
| Syngenta Participations AG | 4970 |
98 |
| The University of Tokyo | 3903 |
92 |
| Kaneka Corporation | 4445 |
82 |
| The Trustees of the University of Pennsylvania | 4122 |
81 |
| Corteva Agriscience LLC | 2494 |
81 |
| Astellas Pharma Inc. | 1145 |
70 |
| Keio University | 1053 |
69 |
| Evogene Ltd. | 223 |
64 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
64 |
| Takeda Pharmaceutical Company Limited | 2961 |
61 |
| Other owners | 12207 |